The latest on treatments for severe COVID-19 cases

Dr. Jen Ashton breaks down the “promising,” “mixed evidence” and “not promising” treatments available right now.
2:24 | 08/05/20

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for The latest on treatments for severe COVID-19 cases
Some of the major developments we're tracking -- deaths around the world due to confirmed cases of coronavirus hit a new high, soaring above 700,000 for the first time, now more than 18.5 million people are known to be infected as more than 11 million recover and with me here leading things off, Dr. And we know that hospital icus in Georgia, Alabama, all reporting that they're at near capacity which brings into question the treatment options that are now available for people who have severe cases of covid-19. Yeah, and that's such a concern, Amy. The good news is that the majority of cases of covid-19 can be managed at home. When you talk about severe cases requiring hospitalization, icu management, lots of medications being studied right now. We divided them up into those showing promising evidence right now, remdesivir, granted emergency use authorization by the fda, people are familiar with that. And a steroid is available in every hospital basically in the world, it's cheap, we've had it for a long time, also showing some promise in clinical trials. There are others that fall fall into a gray zone. Exactly. Those are being considered at this point as showing mixed evidence. As we break them down, one of them is called idd-2801, an oral pill that's showed some promise in human cells and immune therapies, things like convalescent plasma. The inhibitors that work to dampen that major inflammatory response, and then blood thinners, all of these at this point showing what we are referring to as mixed evidence in terms of being effective. And then there are the treatment options that right now have not shown that they do more benefit than harm. Right, and the two big ones I think in that category right now -- hydroxychloroquine and chloroquine, and there's AIDS drugs -- lopinavir and ritonavir also not really showing promising results in clinical trials but I want to be clear as we learn more, all of this may change. It's being aggressively studied not just here in the U.S. But worldwide. Thank you so much, Dr. Jen.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"2:24","description":"Dr. Jen Ashton breaks down the “promising,” “mixed evidence” and “not promising” treatments available right now.","mediaType":"default","section":"ABCNews/GMA","id":"72190705","title":"The latest on treatments for severe COVID-19 cases","url":"/GMA/GMA3/video/latest-treatments-severe-covid-19-cases-72190705"}